reported that the risk of major malformations associated with polytherapy is primarily influenced by VPA and found an interesting trend towards a lower rate of malformations in the VPA + other AEDs group (19.2%) compared to VPA monotherapy (24.0%) for the highest VPA doses (≥1,500 mg/day) [ 59 ].
← all excerpts
Use of Phenytoin, Phenobarbital Carbamazepine, Levetiracetam Lamotrigine and Valproate in Pregnancy and Breastfeeding: Risk of Major Malformations, Dose-dependency, Monotherapy vs Polytherapy, Pharmacokinetics and Clinical Implications.
1
—
—